8.77
前日終値:
$8.99
開ける:
$9.06
24時間の取引高:
3.37M
Relative Volume:
1.41
時価総額:
$1.03B
収益:
$2.35B
当期純損益:
$-74.42M
株価収益率:
-9.3298
EPS:
-0.94
ネットキャッシュフロー:
$150.93M
1週間 パフォーマンス:
-13.85%
1か月 パフォーマンス:
-14.10%
6か月 パフォーマンス:
-71.73%
1年 パフォーマンス:
-74.51%
Evolent Health Inc Stock (EVH) Company Profile
名前
Evolent Health Inc
セクター
電話
571-389-6000
住所
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
EVH を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
EVH
Evolent Health Inc
|
8.77 | 1.03B | 2.35B | -74.42M | 150.93M | -0.94 |
![]()
VEEV
Veeva Systems Inc
|
218.95 | 35.98B | 2.66B | 665.91M | 1.08B | 4.05 |
![]()
SOLV
Solventum Corp
|
80.16 | 13.98B | 8.26B | 66.00M | 1.17B | 0.3682 |
![]()
DOCS
Doximity Inc
|
68.45 | 12.92B | 516.85M | 174.11M | 217.38M | 0.87 |
![]()
TEM
Tempus Ai Inc
|
50.93 | 9.36B | 640.44M | -743.28M | -206.93M | -11.29 |
![]()
HQY
Healthequity Inc
|
104.82 | 9.34B | 1.15B | 96.70M | -161.99M | 1.09 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-01-10 | 開始されました | Needham | Buy |
2024-12-03 | 繰り返されました | BTIG Research | Buy |
2024-11-08 | ダウングレード | Stephens | Overweight → Equal-Weight |
2024-10-11 | 開始されました | KeyBanc Capital Markets | Overweight |
2024-08-09 | アップグレード | Truist | Hold → Buy |
2024-04-22 | 開始されました | Citigroup | Buy |
2024-03-01 | 開始されました | Oppenheimer | Outperform |
2024-01-03 | 開始されました | Barclays | Overweight |
2023-12-06 | 開始されました | JMP Securities | Mkt Outperform |
2023-10-16 | 開始されました | UBS | Buy |
2023-04-12 | 開始されました | Stephens | Overweight |
2022-11-01 | 開始されました | Truist | Hold |
2022-07-29 | 開始されました | RBC Capital Mkts | Outperform |
2022-03-30 | 開始されました | Guggenheim | Buy |
2021-11-18 | アップグレード | JP Morgan | Neutral → Overweight |
2021-04-29 | 再開されました | JP Morgan | Neutral |
2021-01-07 | 開始されました | BTIG Research | Buy |
2020-07-06 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
2020-06-05 | ダウングレード | Goldman | Buy → Neutral |
2020-06-02 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
2018-10-05 | 再開されました | Leerink Partners | Outperform |
2018-06-04 | 開始されました | Piper Jaffray | Overweight |
2018-04-24 | 再開されました | JP Morgan | Neutral |
2017-09-20 | 開始されました | KeyBanc Capital Mkts | Overweight |
2017-06-02 | 開始されました | Robert W. Baird | Outperform |
2017-03-14 | 開始されました | Oppenheimer | Outperform |
2017-01-13 | アップグレード | Wells Fargo | Market Perform → Outperform |
2016-10-28 | 再開されました | JP Morgan | Overweight |
2016-08-05 | 繰り返されました | FBR Capital | Outperform |
2016-07-26 | 開始されました | Jefferies | Buy |
2016-07-13 | 繰り返されました | FBR Capital | Outperform |
2016-03-29 | 開始されました | FBR Capital | Outperform |
2016-01-06 | 開始されました | Canaccord Genuity | Buy |
2015-06-30 | 開始されました | Goldman | Buy |
2015-06-30 | 開始されました | JP Morgan | Overweight |
2015-06-30 | 開始されました | Leerink Partners | Outperform |
2015-06-30 | 開始されました | Sun Trust Rbsn Humphrey | Buy |
すべてを表示
Evolent Health Inc (EVH) 最新ニュース
Evolent Health, Inc. to Host Earnings Call - ACCESS Newswire
Evolent Health Inc Class A to Host Earnings Call - ACCESS Newswire
Relative Strength Alert For Evolent Health - Nasdaq
Evolent Health: Health Insurance Headwinds Aren't Helping BusinessRating Downgrade - Seeking Alpha
How To Trade (EVH) - Stock Traders Daily
Evolent Health stock hits 52-week low at $9.44 amid market challenges - Investing.com Canada
Evolent Health stock hits 52-week low at $9.44 amid market challenges By Investing.com - Investing.com South Africa
Evolent Health's SWOT analysis: stock faces oncology cost headwinds, AI potential By Investing.com - Investing.com South Africa
Evolent Health’s SWOT analysis: stock faces oncology cost headwinds, AI potential - Investing.com
Evolent Health's SWOT analysis: stock faces oncology cost headwinds, AI potential - Investing.com UK
Evolent Health outlines 15%-18% growth target for 2025 amid oncology trend challenges - MSN
Evolent Health price target raised to $13 from $12 at Citizens JMP - TipRanks
Evolent Health stock target raised to $13 at Citizens JMP By Investing.com - Investing.com South Africa
Evolent Health stock target raised to $13 at Citizens JMP - Investing.com India
Evolent Health Inc. Reports Mixed Earnings Results - TipRanks
Evolent Health Reports Growth and Strategic Gains - TipRanks
Hims & Hers Health (HIMS) To Report Earnings Tomorrow: Here Is What To Expect - The Globe and Mail
Evolent Health stock hits 52-week low at $9.55 By Investing.com - Investing.com Nigeria
Evolent Health (EVH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
Analysts Have Lowered Expectations For Evolent Health, Inc. (NYSE:EVH) After Its Latest Results - Simply Wall St
Evolent Health Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Evolent Health’s AI Strategy: Navigating Risks and Challenges Amidst Technological Advancements - TipRanks
Evolent Health Inc Reports Q4 EPS of -$0.27, Narrowly Beating Es - GuruFocus.com
Piper Sandler cuts Evolent Health target to $16, maintains overweight By Investing.com - Investing.com Canada
Evolent Health, Inc. SEC 10-K Report - TradingView
Evolent Health Inc (EVH) Q4 2024 Earnings Report Preview: What T - GuruFocus.com
Evolent Health misses Q4 estimates, shares drop on weak guidance - Investing.com India
Evolent Health Inc (EVH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Oncology ... - Yahoo Finance
Evolent Health Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Evolent Announces Fourth Quarter and Full Year 2024 Results - The Malaysian Reserve
Evolent Health: Q4 Earnings Snapshot - mySA
Evolent Health (NYSE:EVH) Misses Q4 Sales Targets - The Globe and Mail
Evolent Health Inc earnings missed by $0.09, revenue fell short of estimates - Investing.com South Africa
Evolent Health (NYSE:EVH) Misses Q4 Sales Targets By Stock Story - Investing.com Canada
Evolent Health Swings to Q4 Adjusted Loss, Sales Rise; Revenue Guidance Set; Shares Drop After Hours - Marketscreener.com
Evolent Health (EVH) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Evolent Health (EVH) Q4 2024 Earnings Call Transcript - MSN
Evolent Health misses Q4 estimates, shares drop on weak guidance By Investing.com - Investing.com Australia
Evolent Health, Inc. Reports Q4 and Full Year 2024 Financial Results - TradingView
Earnings Flash (EVH) Evolent Health Posts Q4 Revenue $646.5M, vs. FactSet Est of $651.3M - Marketscreener.com
Earnings Flash (EVH) Evolent Health Reports Q4 Adjusted Loss $-0.02 Per Share, vs. FactSet Est of $0.03 - Marketscreener.com
Evolent Health Inc (EVH) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Evolent Health reports Q4 EPS (2c), consensus 1c - TipRanks
Evolent Health (EVH) Q4 Earnings Report Preview: What To Look For - The Globe and Mail
Evolent Health stock hits 52-week low at $9.55 - MSN
Evolent Health (NYSE:EVH) Is Doing The Right Things To Multiply Its Share Price - Yahoo Canada Finance
Humane, the maker of the revolutionary AI gadget AI Pin, is being shut down. How much is HP willing to buy part of the company for? - dev.ua
Evolent Health Inc (EVH) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):